CVS Health Corporation (NYSE:CVS – Get Free Report) was the target of unusually large options trading activity on Wednesday. Investors bought 37,560 call options on the stock. This represents an increase of approximately 59% compared to the average daily volume of 23,606 call options.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on CVS shares. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Wells Fargo & Company decreased their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Robert W. Baird upped their price objective on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $91.00 price target on shares of CVS Health in a research report on Tuesday, January 6th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.86.
Read Our Latest Research Report on CVS
Institutional Trading of CVS Health
CVS Health Stock Performance
Shares of CVS stock traded up $1.82 during midday trading on Wednesday, hitting $81.91. 4,096,064 shares of the company were exchanged, compared to its average volume of 7,633,214. CVS Health has a 52 week low of $52.34 and a 52 week high of $85.15. The firm has a market capitalization of $103.97 billion, a P/E ratio of 215.55, a PEG ratio of 0.72 and a beta of 0.48. The firm’s 50 day moving average price is $78.86 and its two-hundred day moving average price is $74.51. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the business posted $1.09 earnings per share. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts anticipate that CVS Health will post 5.89 earnings per share for the current year.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.
About CVS Health
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Stories
- Five stocks we like better than CVS Health
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
